RIO DE JANEIRO, BRAZIL - The National Health Regulatory Agency (ANVISA) on Friday, July 3rd, released the third trial stage of the vaccine against the novel coronavirus developed by Subscribe to our Premium Membership Plan. Already Subscribed? Login Here